| 2024-05-14 | BioCryst Pharmaceuticals, Inc. BCRX | Chief R&D Officer | 30,000 0.0159% | $5.86 | $175,800 | +18.22% | ||
| 2023-04-03 | Sale | BioCryst Pharmaceuticals, Inc. BCRX | Chief R&D Officer | 7,000 0.0037% | $8.29 | $58,030 | -19.09% | |
| 2022-12-15 | Sale | BioCryst Pharmaceuticals, Inc. BCRX | Chief R&D Officer | 3,125 0.0018% | $10.89 | $34,031 | -30.48% | |
| 2022-04-01 | Sale | BioCryst Pharmaceuticals, Inc. BCRX | Chief R&D Officer | 7,600 0.004% | $16.20 | $123,120 | -34.09% | |
| 2017-12-08 | Sale | GlycoMimetics, Inc. GLYC | SVP Clinical Development, CMO | 4,000 0.0114% | $15.01 | $60,040 | +8.82% | |
| 2017-09-18 | Sale | GlycoMimetics, Inc. GLYC | SVP Clinical Development, CMO | 4,000 0.0114% | $13.00 | $52,000 | +16.14% | |
| 2017-05-25 | Sale | GlycoMimetics, Inc. GLYC | SVP Clinical Development, CMO | 4,000 0.0165% | $15.57 | $62,280 | +1.58% | |
| 2017-05-19 | Sale | GlycoMimetics, Inc. GLYC | SVP Clinical Development, CMO | 4,000 0.014% | $12.14 | $48,560 | +9.64% | |
| 2016-10-03 | Sale | GlycoMimetics, Inc. GLYC | VP Clinical Development, CMO | 8,000 0.0357% | $7.00 | $56,002 | -5.15% | |
| 2016-07-20 | Sale | GlycoMimetics, Inc. GLYC | VP Clinical Development, CMO | 4,000 0.0171% | $8.00 | $32,000 | -20.49% | |
| 2016-07-06 | Sale | GlycoMimetics, Inc. GLYC | VP Clinical Development, CMO | 13,592 0.0589% | $6.68 | $90,795 | -3.74% | |
| 2016-07-05 | Sale | GlycoMimetics, Inc. GLYC | VP Clinical Development, CMO | 20,272 0.0901% | $7.01 | $142,107 | -5.85% | |
| 2016-07-01 | Sale | GlycoMimetics, Inc. GLYC | VP Clinical Development, CMO | 10,136 0.0433% | $7.40 | $75,006 | -14.38% |